Enzon Pharmaceuticals Declares 3% Cash Dividend on Series C Preferred Stock

On December 18, 2024, Enzon Pharmaceuticals, Inc. (OTCMKTS: ENZN) announced through a Form 8-K filing with the Securities and Exchange Commission that its Board of Directors had approved a 3% cash dividend payout. This dividend is directed towards the holders of the company’s 40,000 outstanding shares of Series C Non-Convertible Redeemable Preferred Stock. The total […]

Leave a Reply

Your email address will not be published.

Previous post Canada Carbon (CVE:CCB) Shares Down 33.3% – Time to Sell?
Next post Rock Tech Lithium Inc. (OTCMKTS:RCKTF) Sees Significant Drop in Short Interest